US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Interlinked AB signs contracted distributor agreements across Europe, the Middle East, and North America

Interlinked AB, a Swedish MedTech company with a patented safety connector technology, announces today that it has signed sales distributor agreements across three continents, covering countries in Europe, the Middle East, and North America. The agreements include binding minimum volume commitments. The agreements represent a clear step forward in Interlinked’s international commercial expansion and establish a repeatable, distributor-led sales model across multiple healthcare systems. Interlinked’s safety connector platform, ReLink / LinkUS, is designed to reduce accidental catheter

Interlinked advances to next phase – CE-MDR approved dual-use solution for civilian and military healthcare

[ReLink with reflection 1.png] Interlinked AB announces today that ReLink®, the company’s CE-MDR approved medical device platform, has been approved as a dual-use solution covering both civilian and military healthcare, including medical preparedness and field hospital environments. With recurring sales and clinical use across hospitals in several European countries, ReLink® has already demonstrated strong value for patient safety. ReLink® is the only breakaway connector that remains closed at all times – before, during and after separation. It is designed to reduce accidental

A milestone moment for Interlinked – first major distribution agreement signed with a guaranteed minimum revenue of € 3 million

[SHB_3402.jpg]   Interlinked AB has signed its first major international distribution agreement, with a guaranteed minimum revenue of € 3 million. This marks a significant milestone in the company’s commercialisation journey and reflects the growing demand for ReLink®. The multi-year agreement includes committed volumes and establishes a strong foundation for rapid scale-up across several markets. “This is a pivotal moment for Interlinked. Securing a guaranteed revenue of this size at such an early stage of commercialisation is a clear validation of both the demand and the impact

Tada Group AB signs convertible loan with EIC Fund

Stockholm, 3rd of May 2023 Tada Group AB is delighted to share its latest milestone. Having recently closed a round of 10 million SEK in equity, they have now secured a convertible loan with the EIC Fund advised by the EIB of 9 million SEK. This partnership is a clear demonstration of the company's dedication to bringing innovative solutions to the medical industry. "We are thrilled to have secured this convertible loan with the EIC Fund advised by the EIB," said Katarina Hedbeck, CEO of Tada Group AB. "This funding will help us to execute on our commitments, including advancing our

Tada Group AB Successfully Closes Investment Round in Challenging Market of 2022

Tada Group AB is proud to announce the successful closing of its latest investment round which was concluded despite the challenging market conditions of 2022. The company raised more than 10 million SEK from angel and institutional investors which will be used to increase production capacity as well as initial commercialisation. "Despite the difficulties of raising capital under these tough market conditions, we were able to secure the funding we need to continue growing and innovating ReLink." said Katarina Hedbeck, CEO of Tada Group. The company's product ReLink has

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe

Media